<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="pik3ca-overgrowth" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">pik3ca-overgrowth</book-part-id>
      <title-group>
        <title><italic toggle="yes">PIK3CA</italic>-Related Segmental Overgrowth</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mirzaa</surname>
            <given-names>Ghayda</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Seattle Children&#x02019;s Research Institute<break/>Seattle, Washington</aff>
          <email>gmirzaa@uw.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Conway</surname>
            <given-names>Robert</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Wayne State University<break/>Detroit, Michigan</aff>
          <email>rconway@med.wayne.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Graham</surname>
            <given-names>John M</given-names>
            <suffix>Jr</suffix>
          </name>
          <degrees>MD, ScD</degrees>
          <aff>Cedars Sinai Medical Center<break/>Los Angeles, California</aff>
          <email>john.graham@cshs.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dobyns</surname>
            <given-names>William B</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Seattle Children&#x02019;s Hospital<break/>Seattle, Washington</aff>
          <email>wbd@uw.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>15</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="opd" document-type="chapter">Otopalatodigital Spectrum Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="pink1-pd" document-type="chapter"><italic toggle="yes">PINK1</italic> Type of Young-Onset Parkinson Disease</related-object>
      <abstract id="pik3ca-overgrowth.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth includes disorders of brain (e.g., MCAP [<italic toggle="yes">m</italic>egalencephaly-<italic toggle="yes">cap</italic>illary malformation] syndrome, hemimegalencephaly); and segmental body overgrowth (e.g., CLOVES [<italic toggle="yes">c</italic>ongenital <italic toggle="yes">l</italic>ipomatous asymmetric <italic toggle="yes">o</italic>vergrowth of the trunk, lymphatic, capillary, venous, and combined-type <italic toggle="yes">v</italic>ascular malformations, <italic toggle="yes">e</italic>pidermal nevi, <italic toggle="yes">s</italic>keletal and <italic toggle="yes">s</italic>pinal anomalies] syndrome, fibroadipose hyperplasia [FH]). Heterozygous (usually somatic mosaic) pathogenic variants of <italic toggle="yes">PIK3CA</italic> are causative.</p>
          <p>MCAP syndrome is characterized by the major findings of (1) megalencephaly (MEG) or hemimegalencephaly (HMEG) associated with neurologic findings of hypotonia, seizures, and mild to severe intellectual disability; and (2) cutaneous capillary malformations with focal or generalized somatic overgrowth. Additional findings can include digital anomalies (syndactyly, polydactyly), cortical malformations &#x02013; most distinctively polymicrogyria (PMG); and variable connective tissue dysplasia.</p>
          <p>CLOVES (or CLOVE) syndrome and fibroadipose hyperplasia (FH) may be associated with (1) MEG or HMEG; and (2) patchy segmental overgrowth associated with skeletal anomalies, lipomatosis, vascular malformations, and epidermal nevi.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth is confirmed in an individual with a pathogenic variant on one <italic toggle="yes">PIK3CA</italic> allele, typically in affected tissues. Because the vast majority of <italic toggle="yes">PIK3CA</italic> pathogenic variants arise postzygotic (and are thus mosaic), more than one tissue may need to be tested. Failure to detect a <italic toggle="yes">PIK3CA</italic> pathogenic variant does not exclude a clinical diagnosis of the <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth disorders in individuals with suggestive features.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Significant or lipomatous segmental overgrowth may require debulking; scoliosis and leg-length discrepancy may require orthopedic care and surgical intervention. Neurologic complications (e.g., obstructive hydrocephalus, increased intracranial pressure, progressive and/or symptomatic cerebellar tonsillar ectopia or Chiari malformation; epilepsy in those with HMEG) may warrant neurosurgical intervention. Routine treatment of the following, when present, is indicated: cardiac and renal abnormalities; intellectual disabilities and behavior problems; motor difficulties; speech, swallowing, and feeding difficulties.</p>
          <p>
            <italic toggle="yes">Surveillance:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>MCAP syndrome: Follow up no less than every six months until age six years and at least yearly thereafter to monitor for neurosurgical complications, breathing or sleep disorders, seizures and orthopedic complications. Provisionally recommended imaging in early childhood includes brain MRI every six months for the first two years, then yearly until age eight years for neurologic complications (e.g., hydrocephalus, cerebellar tonsillar ectopia). Consider screening for Wilms tumor following the protocol suggested for Beckwith-Wiedemann syndrome (BWS) (by ultrasound examination every 3 months until age 8 years); however, tumor risk in <italic toggle="yes">PIK3CA</italic>-related segmental overgrowth is undetermined and appears to be lower than in BWS.</p>
            </list-item>
            <list-item>
              <p>CLOVES syndrome and FH: Monitoring for severe scoliosis, infiltrative lipomatous overgrowth, paraspinal high-flow lesions with spinal cord ischemia, lymphatic malformations, cutaneous vesicles, orthopedic problems, central phlebectasias, and thromboembolism.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth is not typically inherited. Most affected individuals with MCAP reported to date (21/24) had somatic mosaicism for pathogenic variants in <italic toggle="yes">PIK3CA,</italic> suggesting that mutation occurred post-fertilization in one cell of the multicellular embryo. Two of 24 affected individuals had a <italic toggle="yes">de novo</italic> germline pathogenic variant in <italic toggle="yes">PIK3CA.</italic> All reported individuals with CLOVES and FH had somatic mosaicism for pathogenic variants in <italic toggle="yes">PIK3CA</italic>. No confirmed instances of vertical transmission or sib recurrence have been reported. Because family members are not known to have an increased risk, prenatal diagnosis is usually not indicated for family members.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="pik3ca-overgrowth.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="pik3ca-overgrowth.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_pik3ca-overgrowth.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">PIK3CA</italic>-Related Segmental Overgrowth: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_pik3ca-overgrowth.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>CLOVES syndrome</p></list-item><list-item><p>Megalencephaly-capillary malformation syndrome (MCAP syndrome)</p></list-item><list-item><p>Fibroadipose hyperplasia</p></list-item><list-item><p>Hemimegalencephaly</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="pik3ca-overgrowth.Nomenclature">Nomenclature</xref>.</p>
            </fn>
            <fn id="pik3ca-overgrowth.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="pik3ca-overgrowth.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="pik3ca-overgrowth.Diagnosis">
        <title>Diagnosis</title>
        <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth includes brain (e.g., megalencephaly-capillary [MCAP] malformation syndrome, hemimegalencephaly) and segmental body overgrowth (e.g., CLOVES syndrome, fibroadipose hyperplasia [FH]) caused by heterozygous (usually somatic mosaic) <italic toggle="yes">PIK3CA</italic> pathogenic variants.</p>
        <sec id="pik3ca-overgrowth.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth <bold>is suspected</bold> in an individual with clinical features of the following syndromes. Of note, some individuals with low-level mosaicism for <italic toggle="yes">PIK3CA</italic> somatic pathogenic variants may have phenotypes that do not meet clinical diagnostic criteria.</p>
          <p><bold>Megalencephaly-capillary malformation (MCAP) syndrome</bold> (<xref ref-type="table" rid="pik3ca-overgrowth.T.findings_in_mcap_syn">Table 1</xref>) (<xref ref-type="fig" rid="pik3ca-overgrowth.F1">Figure 1</xref> and <xref ref-type="fig" rid="pik3ca-overgrowth.F2">Figure 2</xref>) is characterized by the major findings (1) megalencephaly (MEG) (<xref ref-type="fig" rid="pik3ca-overgrowth.F3">Figure 3</xref>) or hemimegalencephaly (HMEG) associated with abnormalities of muscle tone, seizures, and mild to severe intellectual disability, and (2) cutaneous capillary malformations with focal or generalized somatic overgrowth. Additional findings can include digital anomalies consisting of syndactyly and polydactyly; cortical malformations, most distinctively polymicrogyria (PMG) (<xref ref-type="fig" rid="pik3ca-overgrowth.F3">Figure 3</xref>); and variable connective tissue dysplasia [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.franceschini.2000.265">Franceschini et al 2000</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.robertson.2000.1">Robertson et al 2000</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.giuliano.2004.99">Giuliano et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mart_nezglez.2010.3101">Mart&#x000ed;nez-Glez et al 2010</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
          <p>Hemimegalencephaly (HMEG) is characterized by partial or complete enlargement and dysplasia of a cerebral hemisphere, often with variable contralateral involvement. Complex abnormalities (typically noted on brain imaging) include cortical dysgenesis, abnormally increased white matter, and dilated and dysmorphic lateral ventricles [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.barkovich.1990.523">Barkovich &#x00026; Chuang 1990</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.floressarnat.2002.373">Flores-Sarnat 2002</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.floressarnat.2003.776">Flores-Sarnat et al 2003</xref>].</p>
          <table-wrap id="pik3ca-overgrowth.T.findings_in_mcap_syn" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Findings in MCAP Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1" valign="middle" colspan="4" align="left" scope="colgroup" rowspan="1">Finding</th>
                </tr>
                <tr>
                  <th headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1" id="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                  <th headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1" id="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Major</th>
                  <th headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1" id="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Supportive</th>
                  <th headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1" id="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Secondary</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Early segmental<break/>overgrowth <break/>(brain &#x0003e; somatic<break/>tissues)</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Progressive megalencephaly (MEG) or hemimegalencephaly (HMEG)&#x000a0;<sup>1</sup></td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Ventriculomegaly or hydrocephalus<break/>Cerebellar tonsillar ectopia or Chiari malformation<break/>Abnormally thick (mega-) corpus callosum<break/>Congenital somatic overgrowth (generalized/focal)<break/>Somatic or cranial asymmetry</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia<break/>Developmental delay<break/>Distinctive facial features:
<list list-type="bullet"><list-item><p>Frontal bossing</p></list-item><list-item><p>Dolichocephaly</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Developmental<break/>vascular<break/>disorders<break/>(abnormal<break/>vasculogenesis)</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Cutaneous capillary malformations:&#x000a0;<sup>1</sup>
<list list-type="bullet"><list-item><p>Midline face (esp. persistent nevus flammeus)</p></list-item><list-item><p>Body: widespread (or rarely vivid cutis marmorata)</p></list-item></list>
</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Venous aneurysms/prominent venous pattern<break/>Aberrant vasculature/vascular rings</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Digital anomalies</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Syndactyly (2-3, 3-4, 2-3-4):
<list list-type="bullet"><list-item><p>Toes: 2-3 &#x0003e; others</p></list-item><list-item><p>Fingers: 3-4 &#x0003e; others</p></list-item></list>
</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Postaxial polydactyly<break/>Polysyndactyly<break/>Sandal-gap toes</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cortical brain<break/>malformations</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Polymicrogyria (PMG)</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Seizures<break/>Developmental delay</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Connective tissue <break/>dysplasia</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Skin hyperelasticity<break/>Joint hypermobility<break/>Thick, soft, (or &#x0201c;doughy&#x0201d;) subcutaneous tissue</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_1_1 hd_h_pik3ca-overgrowth.T.findings_in_mcap_syn_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">Hypotonia<break/>Gross developmental delay</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Based on <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.franceschini.2000.265">Franceschini et al [2000]</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.robertson.2000.1">Robertson et al [2000]</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.giuliano.2004.99">Giuliano et al [2004]</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al [2004]</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al [2009]</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mart_nezglez.2010.3101">Mart&#x000ed;nez-Glez et al [2010]</xref></p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.1.1">
                <label>1. </label>
                <p>MCAP syndrome can be diagnosed based on clinical findings in individuals with classic features of MEG or HMEG (major finding 1) and characteristic capillary malformations (major finding 2).</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>CLOVES (or CLOVE) syndrome and fibroadipose hyperplasia</bold> (<xref ref-type="table" rid="pik3ca-overgrowth.T.classic_features_of">Table 2</xref>) may be associated with MEG or HMEG, and thus overlap with MCAP syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gucev.2008.2688">Gucev et al 2008</xref>]. Findings include patchy segmental overgrowth associated with skeletal anomalies, lipomatosis, vascular malformations, and epidermal nevi. Given the clinical and molecular genetic overlap between CLOVES syndrome and fibroadipose hyperplasia, these two conditions may constitute a single large spectrum of somatic overgrowth.</p>
          <p>CLOVES syndrome is characterized by <italic toggle="yes">c</italic>ongenital <italic toggle="yes">l</italic>ipomatous asymmetric <italic toggle="yes">o</italic>vergrowth of the trunk, lymphatic, capillary, venous, and combined-type <italic toggle="yes">v</italic>ascular malformations, <italic toggle="yes">e</italic>pidermal nevi, <italic toggle="yes">s</italic>keletal and <italic toggle="yes">s</italic>pinal anomalies. CLOVES syndrome differs from MCAP syndrome by more striking growth dysregulation with complex congenital overgrowth of lipomatous tissues (typically manifest as a truncal lipomatous mass) and combined lymphatic and vascular malformations (<xref ref-type="fig" rid="pik3ca-overgrowth.F4">Figure 4A</xref>). Skeletal anomalies include scoliosis, wide hands and feet, macrodactyly (<xref ref-type="fig" rid="pik3ca-overgrowth.F4">Figure 4B</xref>), and prominent sandal-gap toes [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>].</p>
          <p>Fibroadipose hyperplasia, a severe overgrowth syndrome recently described in ten individuals with mosaic <italic toggle="yes">PIK3CA</italic> pathogenic variants [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>], is characterized by progressive segmental overgrowth of visceral, subcutaneous, muscular, fibroadipose, and skeletal tissues, and may involve the trunk or extremities. Other variable features include lipomatous infiltration of muscle, progressive adipose dysregulation and regional lipohypoplasia, vascular malformations, testicular abnormalities, and polydactyly.</p>
          <table-wrap id="pik3ca-overgrowth.T.classic_features_of" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Classic Features of CLOVES Syndrome and Fibroadipose Hyperplasia (FH)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Feature</th>
                  <th id="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CLOVES Syndrome</th>
                  <th id="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Fibroadipose Hyperplasia (FH)&#x000a0;<sup>1</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Overgrowth</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Lipomatous overgrowth (typically truncal, complex, congenital, progressive)<break/>Spinal-paraspinal extension<break/>Limb &#x00026; digital overgrowth<break/>Bony overgrowth, leg-length discrepancy</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Visceral, subcutaneous, muscular fibroadipose, &#x00026; skeletal tissues (congenital, progressive; may involve trunk or extremities)<break/>Lipomatous infiltration of muscle (in 6/10)<break/>Disproportionate linear overgrowth (in 10/10)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Cutaneous &#x00026;<break/>vascular <break/>malformations</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Low-flow (capillary, venous, lymphatic; typically overlying truncal overgrowth)<break/>High-flow (arteriovenous; esp. spinal-paraspinal)<break/>Venous thrombosis/embolism<break/>Epidermal nevi (single/multiple)</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Vascular malformation (in 2/10)<break/>Epidermal nevi (in 2/10)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Musculoskeletal<break/> / acral<break/>abnormalities</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Scoliosis<break/>Chondromalacia patellae<break/>Dislocated knees<break/>Macrodactyly, wide hands/feet<break/>Sandal gap toes<break/>Symmetric overgrowth feet<break/>Plantar-palmar overgrowth</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Progressive skeletal overgrowth (preserved architecture)<break/>Polydactyly</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Visceral<break/>abnormalities</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Renal agenesis/hypoplasia<break/>Splenic lesions</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Testicular or epididymal cysts and hydrocele (in 3/10)<break/>Non-spleen/thymus visceral overgrowth (in 1/10)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Neurologic<break/>abnormalities</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Neural tube defect<break/>Tethered cord<break/>Megalencephaly/hemimegalencephaly<break/>Chiari malformation<break/>Polymicrogyria</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Other</bold>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_pik3ca-overgrowth.T.classic_features_of_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Regional lipohypoplasia, progressive adipose dysregulation</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pik3ca-overgrowth.TF.2.1">
                <label>1. </label>
                <p>Features variably identified in ten affected individuals</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="pik3ca-overgrowth.Establishing_the_Diagn">
          <title>Establishing the Diagnosis</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth <bold>is confirmed</bold> in an individual with a pathogenic variant on one <italic toggle="yes">PIK3CA</italic> allele who meets clinical criteria. In an individual with ambiguous or mild clinical findings [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>] (<xref ref-type="table" rid="pik3ca-overgrowth.T.summary_of_molecular">Table 3</xref>), identification of a <italic toggle="yes">PIK3CA</italic> pathogenic variant <bold>establishes</bold> the diagnosis of <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth.</p>
          <p>Because the vast majority of reported <italic toggle="yes">PIK3CA</italic> pathogenic variants are postzygotic (and thus mosaic), more than one tissue may need to be tested.</p>
          <list list-type="bullet">
            <list-item>
              <p>Experience suggests that sequence analysis of DNA derived from saliva or skin (whether visibly affected or not) has a higher detection rate than of peripheral blood-derived DNA.</p>
            </list-item>
            <list-item>
              <p>In highly focal disorders such as HMEG, CLOVES, and fibroadipose hyperplasia, pathogenic variants are only detectable in affected tissues. Therefore, absence of a pathogenic variant in a DNA sample is insufficient to exclude the diagnosis [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Failure to detect a <italic toggle="yes">PIK3CA</italic> pathogenic variant does not exclude a clinical diagnosis of <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth disorders in individuals with suggestive features, given that low-level mosaicism is observed in many individuals. Furthermore, locus heterogeneity is a possibility (see <xref ref-type="sec" rid="pik3ca-overgrowth.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
            </list-item>
            <list-item>
              <p>Sensitivity to detect low-level mosaicism of a <italic toggle="yes">PIK3CA</italic> pathogenic variant is theoretically greatest using massively parallel sequencing (also known as next-generation sequencing) in tissues other than blood, and in particular will be of high yield when analyzing affected tissues in disorders other than MCAP syndrome.</p>
            </list-item>
          </list>
          <table-wrap id="pik3ca-overgrowth.T.summary_of_molecular" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">PIK3CA</italic>-associated Segmental Overgrowth</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">PIK3CA</italic>
                  </td>
                  <td headers="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_pik3ca-overgrowth.T.summary_of_molecular_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Dependent on phenotype, tissue analyzed, and method&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="pik3ca-overgrowth.TF.3.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="pik3ca-overgrowth" object-id="pik3ca-overgrowth.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="pik3ca-overgrowth.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.5">
                <label>5. </label>
                <p>Most identified <italic toggle="yes">PIK3CA</italic> pathogenic variants to date are missense, with only a single in-frame 3-bp deletion identified in MCAP syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. No nonsense or splice site variants, large deletions, or duplications involving <italic toggle="yes">PIK3CA</italic> have been identified to date.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.6">
                <label>6. </label>
                <p>For MCAP syndrome: 21/24 individuals had somatic mosaicism for a <italic toggle="yes">PIK3CA</italic> pathogenic variant; 2/24 had a <italic toggle="yes">de novo PIK3CA</italic> germline variant; and 1/24 had inconclusive results with only one sample available for testing [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. The level of mosaicism varied by the tissue being tested and ranged from 1% to 48%. In individuals in whom three or more tissues were analyzed, blood was the tissue in which the lowest level of mosaicism was observed [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. The level of mosaicism was below 25% in 15 of 18 (83%) samples of blood-derived DNA and in 11 of 22 (45%) samples of saliva- or skin-derived DNA. Detection of these pathogenic variants was facilitated by massively parallel sequencing and would likely have been missed by standard Sanger sequence analysis.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.7">
                <label>7. </label>
                <p>For CLOVES, FH, HMEG: Pathogenic variants were identified in affected tissues (including brain in hemimegalencephaly) with mutated allele frequencies ranging from 1% to 49% overall. The pathogenic variants were not identified in DNA derived from blood (or, in some studies, from either blood or saliva) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>].</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.3.8">
                <label>8. </label>
                <p>For HMEG: The same <italic toggle="yes">PIK3CA</italic> pathogenic variant (<xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">c.1633G&#x0003e;A</xref>) was identified in four brain samples of affected individuals.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.Clinical_Characteristi">
        <title>Clinical Characteristics</title>
        <sec id="pik3ca-overgrowth.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth includes disorders of brain overgrowth (the megalencephaly-capillary (MCAP) malformation syndrome and hemimegalencephaly) and lipomatous body overgrowth (CLOVES syndrome, and fibroadipose hyperplasia [FH]) caused by heterozygous (usually somatic mosaic) <italic toggle="yes">PIK3CA</italic> pathogenic variants.</p>
          <sec id="pik3ca-overgrowth.MegalencephalyCapillar">
            <title>Megalencephaly-Capillary Malformation (MCAP) Syndrome</title>
            <p>The MCAP syndrome involves striking growth dysregulation manifesting as overgrowth of the brain and multiple somatic tissues. The features vary widely in number and severity among affected individuals.</p>
            <p>Those with classic features have congenital or early postnatal megalencephaly (MEG; occipitofrontal circumference [OFC] &#x02265;3 SD above the mean); segmental or generalized somatic overgrowth; single or generalized capillary malformations (most commonly a midline facial capillary malformation, or cutis marmorata); and generalized hypotonia.</p>
            <p>Megalencephaly (MEG). In some instances, MEG (with or without ventriculomegaly) is detected prenatally on ultrasound examination [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.vogels.1998.245">Vogels et al 1998</xref>,<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.robertson.2000.1">Robertson et al 2000</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.nyberg.2005.129">Nyberg et al 2005</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.coste.2012.917">Coste et al 2012</xref>]. More than 90% of affected children have congenital MEG that is universally progressive [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.vogels.1998.245">Vogels et al 1998</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.robertson.2000.1">Robertson et al 2000</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.nyberg.2005.129">Nyberg et al 2005</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.coste.2012.917">Coste et al 2012</xref>]. A few affected children have normal head size at birth but develop progressive MEG within the first year of life [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p>In a review of 21 children with MCAP syndrome and other published and unpublished cases [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>; Author, unpublished data], birth occipitofrontal circumference (OFC) typically ranges from +2 to +7 standard deviations (SDs) above the mean for gestational age. Most children cross OFC percentiles during the first year of life and, although head growth may level off in early childhood, it typically remains at +3 SD or more above the mean.</p>
            <p>In children who have undergone neurosurgical shunting for obstructive ventriculomegaly or hydrocephalus, head growth noticeably continues at an accelerated pace, indicating the primary nature of MEG in this syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007a.296">Conway et al 2007a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p>Adult OFCs range from +2 to as large as +10 SDs above the mean.</p>
            <p>The process of generalized brain overgrowth may be accompanied by secondary overgrowth of specific brain structures such as the ventricles, corpus callosum, and cerebellum resulting in ventriculomegaly, a markedly thick corpus callosum, and cerebellar tonsillar ectopia with crowding of the posterior fossa, respectively [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p><bold>Neurosurgical complications.</bold> Given the significant MEG, most individuals with MCAP syndrome undergo brain imaging shortly after birth or within the first year of life leading to early identification of key neuroimaging features discussed below [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.vogels.1998.245">Vogels et al 1998</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.nyberg.2005.129">Nyberg et al 2005</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007a.296">Conway et al 2007a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mart_nezlage.2010.13">Mart&#x000ed;nez-Lage et al 2010</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>]. (See <xref ref-type="fig" rid="pik3ca-overgrowth.F4">Figure 4</xref>.)</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Ventriculomegaly and hydrocephalus.</bold> Most affected children have evidence of ventricular dilatation or ventriculomegaly on early brain imaging. In a large review of the neuroimaging findings in MCAP syndrome, 37 out of 65 (56%) children had ventriculomegaly ranging from mild to frank hydrocephalus, with or without cerebellar tonsillar ectopia [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>]. While it is unclear whether or not ventriculomegaly is obstructive in all these individuals, more than half of affected children undergo ventricular shunting, usually within the first year of life.</p>
              </list-item>
              <list-item>
                <p><bold>Cerebellar tonsillar ectopia (CBTE).</bold> A large cerebellum, combined with a small posterior fossa leading to cerebellar tonsillar ectopia, or a Chiari malformation, and syringomyelia are potentially common complications in MCAP syndrome. Fifteen of 65 reported cases have evidence of CBTE with or without herniation [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>]. The degree of ectopia is best objectively assessed by measuring the distance of the cerebellar tonsils below the foramen magnum. Unlike ventriculomegaly, CBTE is rarely congenital in MCAP syndrome.</p>
                <p>The symptoms of a Chiari malformation in children are often difficult to assess and include neck pain or headache, motor weakness, sensory changes, vision problems, swallowing difficulties, or behavioral changes. Infants may have difficulty swallowing, irritability, excessive drooling, or breathing problems, especially central apnea. In two individuals spontaneous &#x0201c;resolution&#x0201d; of CBTE&#x0201d; on follow-up imaging was attributed to disproportionately accelerated skull overgrowth [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
              </list-item>
            </list>
            <p><bold>Cortical brain malformation and polymicrogyria (PMG).</bold> While few reports of PMG with MCAP syndrome appeared in the early literature, it is now clear that it may be present in more than 50% of affected children [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>; Authors, unpublished data]. The most common type of PMG in MCAP syndrome is bilateral perisylvian PMG, although other types including bilateral frontal and focal PMG occur. PMG broadly, and bilateral perisylvian PMG in particular, increase the risk for: epilepsy; oral motor weakness leading to feeding, swallowing and expressive language difficulties; developmental delay; and tone abnormalities.</p>
            <p>Younger children with PMG (specifically of the frontal region) have hypotonia, are not spastic, and may have pseudobulbar problems, whereas older children often have spasticity and pseudobulbar problems [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p><bold>Intellectual disability.</bold> Most individuals with MCAP syndrome have some degree of intellectual disability, although the degree is broad and ranges from mild learning disability to severe disability. Most have mild-moderate delays yet continue to make steady developmental progress, albeit at a slower rate than average. A few (&#x0003c;10%) have severe handicaps. The range of expected milestone acquisition has not yet been clarified in MCAP.</p>
            <p>The degree of intellectual disability appears to be mostly related to the presence and severity of seizures, cortical dysplasia (e.g., PMG), and hydrocephalus. Gross motor delays are probably caused by multiple factors in the individual patient and include MEG, cortical brain malformations, hypotonia, limb asymmetry or overgrowth, and connective tissue dysplasia.</p>
            <p><bold>Autistic features and other behavioral abnormalities.</bold> A subset of children (6/21) with MCAP syndrome have autism or autistic features [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>], suggesting that autism may be part of the neurocognitive profile of a minority of individuals with this MEG syndrome, similar to <italic toggle="yes">PTEN</italic>-related disorders [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mcbride.2010.137">McBride et al 2010</xref>]. Other behavioral abnormalities seen in one or a few children include attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive tendencies, and anxiety-related issues.</p>
            <p><bold>Seizures.</bold> Approximately 30% of individuals with MCAP syndrome have seizures. In some children, seizures are mild and consist of a few episodes that do not warrant long-term antiepileptic drug therapy. In others, seizures may be severe, correlating strongly with the presence of severe and more diffuse cortical dysgenesis, particularly PMG [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p>Children with MCAP syndrome and hemimegalencephaly usually have more severe seizures of earlier onset and poor neurocognitive outcome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.barkovich.2005.1873">Barkovich et al 2005</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>].</p>
            <p><bold>Tone abnormalities.</bold> Hypotonia, and particularly neonatal hypotonia, is a frequent finding in MCAP syndrome. This may be primarily central (secondary to MEG and associated brain abnormalities) and partially peripheral (secondary to mild connective tissue dysplasia resulting in lax joints).</p>
            <p><bold>Vascular malformations.</bold> The majority of children with MCAP syndrome have a capillary type of vascular malformation. Most common are capillary malformations in the mid-facial region (forehead, upper lip and philtrum; such as a persistent nevus flammeus) and generalized or extensive capillary malformations, resembling cutis marmorata. While these lesions may fade as the child grows older, they often persist to some degree and appearance may vary with changes in temperature or temperament [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.toriello.2007.3009">Toriello &#x00026; Mulliken 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>].</p>
            <p>Other vascular abnormalities seen less frequently include infantile hemangiomas (cutaneous, subcutaneous, visceral) that may or may not involute later on in life, dilated and prominent cutaneous and intracranial venous networks, aberrant vasculature in various locations (such as periorbital and cardiac vessels), venous malformations, and vascular rings. Some children undergo laser therapy of cutaneous lesions with no observed recurrences [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.yano.2001.149">Yano &#x00026; Watanabe 2001</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.akcar.2004.261">Akcar et al 2004</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>; <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>; Authors, unpublished data].</p>
            <p>Notably, some individuals with MCAP syndrome have experienced venous thrombosis, and one individual had a large tufted angioma of the shoulder complicated by Kasabach-Merritt syndrome in infancy [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>].</p>
            <p><bold>Somatic overgrowth and asymmetry.</bold> Most children with MCAP syndrome are large (or macrosomic) at birth [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al 2004</xref>]. Data suggest that height and weight normalize in most children; however, postnatal growth delay due to growth hormone deficiency of unknown cause has been reported in a few children [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007a.296">Conway et al 2007a</xref>].</p>
            <p>Some individuals manifest focal or segmental overgrowth of a limb or a few digits, resulting in somatic asymmetry. This focal overgrowth is milder than that in CLOVES syndrome. Furthermore, it is congenital and not relentlessly progressive, unlike that in Proteus syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.biesecker.1999.389">Biesecker et al 1999</xref>]. Focal or unilateral skeletal overgrowth resulting in leg-length discrepancy is common in MCAP syndrome.</p>
            <p><bold>Digital anomalies.</bold> The most common digital anomaly in MCAP syndrome is cutaneous syndactyly, particularly of toes 2-3 or fingers 3-4. Postaxial polydactyly is also common and some individuals have both (i.e., polysyndactyly). Other less common digital anomalies include sandal-gap (increased gap between) toes, broad thumbs and toes, and hypoplastic and deep-set nails.</p>
            <p><bold>Connective tissue dysplasia.</bold> Individuals with MCAP syndrome manifest varying degrees of connective tissue dysplasia. The most prominent feature of this is soft and redundant (often described as &#x0201c;doughy&#x0201d;) subcutaneous tissue. Variable degrees of skin hyperelasticity, joint hypermobility, and ligamentous laxity may also be evident on close examination. These changes are often more severe when coexistent with extensive capillary malformations. Combined with generalized hypotonia and the brain abnormalities, they contribute to early gross motor delays.</p>
            <p>In a few cases, connective tissue involvement leads to congenital dislocation of the joints, including the hips or knees.</p>
            <p><bold>Facial features.</bold> The most striking facial feature in individuals with MCAP syndrome is frontal bossing secondary to significant MEG. The face maybe rounded due to overgrowth or increased subcutaneous tissue, or asymmetric due to focal somatic overgrowth. Coarsening of the facial features with prominent lips is common; characteristic ear abnormalities are seen less often [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>]. No other dysmorphic facial features are consistently observed [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mart_nezglez.2010.3101">Mart&#x000ed;nez-Glez et al 2010</xref>].</p>
            <p><bold>Cardiovascular abnormalities.</bold> A few children with MCAP syndrome have isolated structural heart disease, such as a single ventricular septal defect (VSD) or atrial septal defect (ASD), of unknown pathogenesis.</p>
            <p>More importantly, complex cardiovascular abnormalities involving structural and vascular lesions have been seen in a few affected individuals, including combined ASD with dilated left atrium and mitral valve regurgitation [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.yano.2001.149">Yano &#x00026; Watanabe 2001</xref>]; ASD with a giant atrial septal aneurysm [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.akcar.2004.261">Akcar et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.dinleyici.2004.366">Dinleyici et al 2004</xref>]; ASD, VSD, right-sided aortic arch with an aberrant subclavian artery [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>]; two muscular VSDs and a vascular ring [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>]; and tetralogy of Fallot [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.ercan.2013.115">Ercan et al 2013</xref>].</p>
            <p>Arrhythmias in the fetus or newborn have been reported, overlapping with those above, including atrial flutter in three individuals [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.yano.2001.149">Yano &#x00026; Watanabe 2001</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>] and supraventricular tachycardia in two [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kuint.2012.384">Kuint et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>]. Cardiorespiratory arrest has occurred in some secondary to these heart abnormalities.</p>
            <p>Furthermore, four children with complex congenital heart disease and/or cardiac rhythm abnormalities experienced sudden cardiorespiratory arrest (ages 17 days &#x02013; 19 months) presumably secondary to these cardiac abnormalities [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.yano.2001.149">Yano &#x00026; Watanabe 2001</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.akcar.2004.261">Akcar et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007a.296">Conway et al 2007a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kuint.2012.384">Kuint et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.ercan.2013.115">Ercan et al 2013</xref>].</p>
            <p><bold>Gastrointestinal problems.</bold> Individuals with MCAP syndrome occasionally have feeding and swallowing difficulties due to a number of factors, including the underlying brain abnormalities, particularly PMG, poor tone, and gastroesophageal reflux disease (GERD). Furthermore, two individuals with MCAP syndrome and intestinal lymphangiectasias have been reported, suggesting the association of MCAP with lymphatic abnormalities [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.thong.1999.283">Thong et al 1999</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.m_garban_.2003.184">M&#x000e9;garban&#x000e9; et al 2003</xref>].</p>
            <p><bold>Tumors.</bold> Many benign and a few malignant tumors have been reported in MCAP syndrome. Malignant tumors seen in individuals with MCAP syndrome include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Wilms tumor in two children (ages 10 months and 4 years) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lapunzina.2004.45">Lapunzina et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>]</p>
              </list-item>
              <list-item>
                <p>Leukemia in an 18-year-old [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>]</p>
              </list-item>
              <list-item>
                <p>Meningiomas in two children (ages 21 months and 5 years) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.conway.2007b.2981">Conway et al 2007b</xref>]</p>
              </list-item>
            </list>
            <p>Overall, the risk for malignancy in MCAP syndrome appears to be lower than in <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedemann syndrome</related-object>, as there are reports of malignancy in only three of approximately 150 (2%) individuals. Note: By adding meningiomas, the risk increases marginally to 5/150 (3.3%) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.debaun.1998.398">DeBaun &#x00026; Tucker 1998</xref>].</p>
            <p>The most common benign tumors in MCAP are vascular, described variably as (cavernous) hemangiomas, angiomata, angiomyolipomas, and vascular masses [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.claytonsmith.1997.291">Clayton-Smith et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mart_nezglez.2010.3101">Mart&#x000ed;nez-Glez et al 2010</xref>]. While most common in skin or subcutaneous tissue, hemangiomas have been described in viscera and skull. Several individuals with MCAP also have lipomas that typically remain stable in size, and at least one individual had multiple lipomas [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            <p>See Molecular Genetics, <xref ref-type="sec" rid="pik3ca-overgrowth.Cancer_and_Benign_Tumo">Cancer and Benign Tumors</xref> for additional information.</p>
          </sec>
          <sec id="pik3ca-overgrowth.CLOVES_Syndrome">
            <title>CLOVES Syndrome</title>
            <p>CLOVES syndrome (<italic toggle="yes">c</italic>ongenital <italic toggle="yes">l</italic>ipomatous asymmetric <italic toggle="yes">o</italic>vergrowth of the trunk, lymphatic, capillary, venous, and combined-type <italic toggle="yes">v</italic>ascular malformations, <italic toggle="yes">e</italic>pidermal nevi, <italic toggle="yes">s</italic>keletal and <italic toggle="yes">s</italic>pinal anomalies) is a severe overgrowth disorder characterized by focal and congenital lipomatous overgrowth, various vascular and lymphatic malformations, epidermal nevi, acral and musculoskeletal abnormalities, and renal anomalies, among other minor features.</p>
            <p><bold>Somatic overgrowth.</bold> Newborns typically have complex lipomatous overgrowth of the thoracic and abdominal wall, often with overlying vascular malformations. Variable contiguous extension to the groin, retroperitoneum, mediastinum, and gluteal area may occur. This overgrowth varies in extent and can be unilateral or bilateral at onset. In some cases, the lipomatous overgrowth or mass is identified prenatally on ultrasound examination. Overlying vascular malformations can be capillary, lymphatic, venous, or arteriovenous [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>].</p>
            <p>Other manifestations of overgrowth include symmetric overgrowth with splaying of the feet, macrodactyly, and plantar or palmar overgrowth which results in wrinkling of the overlying palmar or plantar skin distinct from the classic cutaneous connective tissue nevi (CCTN) in <related-object link-type="booklink" source-id="gene" document-id="proteus" document-type="chapter">Proteus syndrome</related-object>.</p>
            <p><bold>Vascular malformations and epidermal nevi.</bold> Both low-flow (capillary, venous, and lymphatic) and high-flow (arteriovenous) malformations occur.</p>
            <p>Lymphatic malformations and vesicles within the classic truncal lipomatous overgrowth may occur, and can be complicated by recurrent infections.</p>
            <p>High-flow lesions (arteriovenous malformations) within and around the lipomatous mass and in the paraspinal regions are common. These lesions can be associated with severe sequelae (see <xref ref-type="sec" rid="pik3ca-overgrowth.Clinical_Description">Clinical Description</xref>, <bold>Neurologic and spinal complications</bold>) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.1812">Alomari et al 2011</xref>].</p>
            <p>Venous malformations (phlebectasia), typically of the thoracic or central veins and prominent superficial veins have been reported. Deep vein thrombosis and pulmonary embolism are potentially fatal complications [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2010.459">Alomari et al 2010</xref>].</p>
            <p>Epidermal nevi are common, particularly when overlying lipomatous overgrowth [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>].</p>
            <p><bold>Musculoskeletal and acral malformations.</bold> Skeletal anomalies can be markedly deforming. The most common is progressive scoliosis ranging from mild to severe [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009b.294">Alomari 2009b</xref>].</p>
            <p>Additional abnormalities include abnormal vertebral bodies, chondromalacia patellae, knee dislocation, wide hands and feet, wide sandal gap, macrodactyly, and talipes equinovarus. Marked bony overgrowth can result in significant leg length discrepancy necessitating surgery. Hip dysplasia requiring surgical intervention has been reported [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.klein.2012.1690">Klein et al 2012</xref>].</p>
            <p>Abnormalities seen occasionally include pectus excavatum and postaxial polydactyly [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.klein.2012.1690">Klein et al 2012</xref>].</p>
            <p><bold>Neurologic and spinal complications.</bold> Direct extension of the lipomatous overgrowth into the paraspinal and intraspinal spaces is associated with high risks for compression of the cord, thecal sac, and nerve roots.</p>
            <p>Some individuals have debilitating spinal myopathy due to the fast-flow spinal-paraspinal vascular lesions [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.1812">Alomari et al 2011</xref>]. Additionally, tethered cord, vertebral anomalies, neural tube defects, and spasticity are common.</p>
            <p>Individuals with CLOVES syndrome have variable degrees of intellectual disability [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>]. Their brain malformations overlap with those in MCAP syndrome: macrocephaly with polymicrogyria and seizures resulting in death at age nine weeks [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>]; hemimegalencephaly with agenesis of the corpus callosum [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gucev.2008.2688">Gucev et al 2008</xref>]; and Chiari malformations [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.1812">Alomari et al 2011</xref>].</p>
            <p><bold>Renal and other visceral complications.</bold> Renal agenesis/hypoplasia, as well as renal calculi and hematuria have been seen in individuals with CLOVES syndrome. Other visceral anomalies include splenic lesions and extensive deep retroperitoneal, pelvic fatty and lymphatic malformation [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.215">Alomari 2011</xref>].</p>
            <p><bold>Tumors.</bold> Tumors reported in CLOVES syndrome include chorangioma, extradural spinal tumor, hemangioma, and multiple angiomatosis (one each) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>].</p>
          </sec>
          <sec id="pik3ca-overgrowth.Fibroadipose_Hyperplas">
            <title>Fibroadipose Hyperplasia (FH)</title>
            <p>Fibroadipose hyperplasia is a severe progressive segmental overgrowth syndrome reported in ten individuals [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>]. This disorder overlaps clinically and molecularly with CLOVES syndrome.</p>
            <p><bold>Segmental overgrowth.</bold> FH is characterized by severe segmental overgrowth of subcutaneous, muscular, and visceral fibroadipose tissue with skeletal overgrowth resulting in asymmetry. The extent of overgrowth varied among individuals, but was extensive in some and progressed into adulthood. Eight of ten individuals underwent multiple debulking or orthopedic procedures.</p>
            <p>Seven of eight individuals on whom records were available had congenital asymmetric overgrowth. Four had skeletal overgrowth with preserved architecture. Bone age, when assessed, was normal.</p>
            <p>Notably, four individuals had marked lipoatrophy in areas not affected by overgrowth without evidence of hypoglycemia or insulin resistance.</p>
            <p><bold>Other abnormalities</bold> include the following (summarized in <xref ref-type="table" rid="pik3ca-overgrowth.T.classic_features_of">Table 2</xref>):</p>
            <list list-type="bullet">
              <list-item>
                <p>Cutaneous capillary vascular malformations (2 individuals)</p>
              </list-item>
              <list-item>
                <p>Testicular or epididymal abnormalities (3 individuals)</p>
              </list-item>
              <list-item>
                <p>Epidermal nevi (2 individuals)</p>
              </list-item>
              <list-item>
                <p>Polydactyly (1 individual)</p>
              </list-item>
            </list>
            <p>All ten individuals with FH had normal intellect.</p>
          </sec>
        </sec>
        <sec id="pik3ca-overgrowth.GenotypePhenotype_Corr">
          <title>Genotype-Phenotype Correlations</title>
          <p>Analysis of <italic toggle="yes">PIK3CA</italic> pathogenic variants in neoplastic tissues of individuals without <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth has identified four mutational hot spots (see <xref ref-type="sec" rid="pik3ca-overgrowth.Molecular_Genetics">Molecular Genetics</xref> and <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>).</p>
          <p>Interestingly, preliminary genotype-phenotype analysis of individuals with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth suggests that MCAP syndrome is primarily associated with <italic toggle="yes">PIK3CA</italic> pathogenic variants not commonly identified in tumors, whereas hemimegalencephaly, CLOVES syndrome, and fibroadipose hyperplasia are associated with <italic toggle="yes">PIK3CA</italic> pathogenic variants at the cancer-related mutational hot spots (see <xref ref-type="sec" rid="pik3ca-overgrowth.Molecular_Genetics">Molecular Genetics</xref>, <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>, and <xref ref-type="table" rid="pik3ca-overgrowth.T.common_cancerrelated">Table 5</xref>).</p>
        </sec>
        <sec id="pik3ca-overgrowth.Penetrance">
          <title>Penetrance</title>
          <p>Degree of incomplete penetrance cannot be assessed in a mosaic genetic disorder.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Nomenclature">
          <title>Nomenclature</title>
          <p><bold>Megalencephaly-capillary malformation</bold> (<bold>MCAP) syndrome</bold> has been renamed several times as understanding of its distinguishing features (particularly the cutaneous vascular anomalies) evolved.</p>
          <list list-type="bullet">
            <list-item>
              <p>Originally termed the macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.moore.1997.67">Moore et al 1997</xref>], the name was later shortened to &#x0201c;macrocephaly-cutis marmorata&#x0201d; (M-CM) syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.cohen.2003.49">Cohen 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>When it was recognized that the terms used for the characteristic cutaneous vascular anomalies were misnomers, the term &#x0201c;macrocephaly-capillary malformation&#x0201d; syndrome was adopted [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.toriello.2007.3009">Toriello &#x00026; Mulliken 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.wright.2009.287">Wright et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>The name was further refined to &#x0201c;megalencephaly-capillary malformation&#x0201d; (MCAP) syndrome, emphasizing that this is true megalencephaly rather than &#x0201c;macrocephaly,&#x0201d; a less specific term denoting a large head due to numerous causes [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="pik3ca-overgrowth.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of <italic toggle="yes">PIK3CA</italic>-associated overgrowth is difficult to estimate due to variation in ascertainment and the broad phenotypic spectrum. Many individuals have atypical or mild phenotypes leading to misidentification.</p>
          <p><italic toggle="yes">PIK3CA</italic>-associated overgrowth has been reported in individuals of various ethnic backgrounds.</p>
          <p>More than 150 individuals have been reported with MCAP syndrome. Some previously reported as Proteus syndrome or KTS undoubtedly had this disorder; therefore, MCAP syndrome is believed to be a common overgrowth syndrome.</p>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.Genetically_Related_Al">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Isolated macrodactyly.</bold> Mosaicism for <italic toggle="yes">PIK3CA</italic> pathogenic gain-of-function variants has been identified in individuals with type I macrodactyly, the most common form of congenital isolated limb overgrowth. These individuals lack vascular malformations and overgrowth involving other body parts [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rios.2013.444">Rios et al 2013</xref>]. Notably, the mosaic <italic toggle="yes">PIK3CA</italic> pathogenic variants in these individuals were identified in affected peripheral nerve cells and were absent from blood.</p>
        <p><bold>Klippel-Trenaunay syndrome (KTS).</bold> Mosaicism for a <italic toggle="yes">PIK3CA</italic> pathogenic variant has been identified in three of 15 individuals with a diagnosis of KTS (but on whom no clinical details were provided), suggesting a causal relationship between a KTS-like phenotype and <italic toggle="yes">PIK3CA</italic> [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>]. Note: It can be questioned whether these individuals had bona fide KTS because of the lack of accompanying clinical details.</p>
        <p><bold>Cowden syndrome.</bold> Recently, germline <italic toggle="yes">PIK3CA</italic> pathogenic variants were identified in eight individuals with a clinical diagnosis of Cowden syndrome and &#x0201c;Cowden-like&#x0201d; features suggesting that germline <italic toggle="yes">PIK3CA</italic> pathogenic variants are associated with these phenotypes [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.orloff.2013.76">Orloff et al 2013</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> Tumor Hamartoma Syndrome</related-object>.</p>
      </sec>
      <sec id="pik3ca-overgrowth.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A number of overgrowth and megalencephaly disorders overlap with the <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth syndromes, including the following.</p>
        <p><bold>Hemimegalencephaly (HMEG)</bold> is characterized by enlargement and dysplasia of all or part of a cerebral hemisphere. In addition to CLOVES syndrome (discussed in this <italic toggle="yes">GeneReview</italic>), it can be isolated but has also been reported in association with disorders of focal somatic overgrowth and/or vascular malformations such as Klippel Trenauany syndrome, hypomelanosis of Ito, <related-object link-type="booklink" source-id="gene" document-id="proteus" document-type="chapter">Proteus syndrome</related-object>, linear nevus sebaceous syndrome, <related-object link-type="booklink" source-id="gene" document-id="tuberous-sclerosis" document-type="chapter">tuberous sclerosis complex</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="bcns" document-type="chapter">nevoid basal cell carcinoma</related-object> [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.abdelhalim.2003.534">Abdelhalim et al 2003</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sharma.2009.12">Sharma et al 2009</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.pavlidis.2012.332">Pavlidis et al 2012</xref>]. Besides <italic toggle="yes">PIK3CA</italic>, mosaic pathogenic variants in other genes of the PI3K-AKT pathway (see <xref ref-type="sec" rid="pik3ca-overgrowth.Molecular_Genetic_Path">Molecular Genetic Pathogenesis</xref>), including <italic toggle="yes">AKT3</italic> and <italic toggle="yes">MTOR,</italic> have been identified in brain tissue from individuals with HMEG [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.poduri.2012.41">Poduri et al 2012</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="mpph" document-type="chapter"><bold>Megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome</bold></related-object> was first described in 2004 and has since been reported in 29 individuals [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2004.353">Mirzaa et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.colombani.2006.466">Colombani et al 2006</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.garavelli.2007.200">Garavelli et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.tohyama.2007.148">Tohyama et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.pisano.2008.916">Pisano et al 2008</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.tore.2009.1620">Tore et al 2009</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.osterling.2011.370">Osterling et al 2011</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kariminejad.2013.651">Kariminejad et al 2013</xref>]. This disorder is characterized by significant, and most often congenital, megalencephaly (MEG), bilateral perisylvian polymicrogyria (PMG), postaxial polydactyly, and an increased risk for hydrocephalus. While its four core features, and primarily the neuroimaging manifestations, overlap with MCAP syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>], MPPH syndrome can be primarily distinguished by the absence of vascular malformations, focal somatic overgrowth, and connective tissue dysplasia [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.verkerk.2010.1488">Verkerk et al 2010</xref>]. <italic toggle="yes">De novo</italic> germline pathogenic variants in <italic toggle="yes">PIK3R2</italic> and <italic toggle="yes">AKT3</italic>, two other core components of the PI3K-AKT pathway, have been identified in MPPH syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>].</p>
        <p><bold>Klippel-Trenaunay syndrome (KTS)</bold> is characterized by disproportionate growth disturbance combined with cutaneous capillary, lymphatic, and venous malformations. KTS typically involves the lower extremities but may affect the upper extremities and may be bilateral. The findings are typically focal and usually spare the craniofacial region, distinguishing it from the more generalized overgrowth observed in <italic toggle="yes">PI3KCA</italic>-related segmental overgrowth syndromes [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.oduber.2011.262">Oduber et al 2011</xref>].</p>
        <p><bold>Bannayan-Riley-Ruvalcaba syndrome (BRRS),</bold> the most severe end of the <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic>-related overgrowth spectrum</related-object>, is characterized by macrocephaly, developmental delay, lipomatosis, intestinal hamartomatous polyposis, and pigmented macules of the penis. While capillary malformations have been seen in BRRS, they are typically isolated and not similar to the capillary malformations in MCAP syndrome. Furthermore, BRRS lacks the significant overgrowth (particularly the truncal lipomatous overgrowth), acral deformities, and other characteristic features of CLOVES syndrome and fibroadipose hyperplasia. BRRS is caused by germline pathogenic variants in <italic toggle="yes">PTEN</italic>. Most individuals with BRRS have normal intelligence.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="proteus" document-type="chapter"><bold>Proteus syndrome</bold></related-object><bold>,</bold> a severe overgrowth syndrome, is associated with disproportionate and asymmetric postnatal somatic overgrowth including skeletal overgrowth, cerebriform connective tissue nevi (CCTN), epidermal nevi, dysregulated adipose tissue, and vascular malformations. Proteus syndrome can be primarily distinguished from CLOVES syndrome and fibroadipose hyperplasia by the postnatal onset of overgrowth. Furthermore, Proteus syndrome lacks the characteristic truncal fatty-vascular mass, spinal paraspinal fast-flow lesions and the acral abnormalities characteristic of CLOVES syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.biesecker.1999.389">Biesecker et al 1999</xref>]. Severely deforming and progressive skeletal overgrowth and poor prognosis occur in both disorders. Mosaic pathogenic variants in <italic toggle="yes">AKT1</italic> were identified in affected tissues of individuals with Proteus syndrome [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2011.611">Lindhurst et al 2011</xref>].</p>
        <p><bold>Hemihyperplasia-multiple lipomatosis (HHML)</bold>
<bold>syndrome</bold>, a distinct milder form of overgrowth, is characterized by moderate somatic asymmetry and overgrowth with subcutaneous lipomas and occasional vascular malformations, but lacks deep vascular malformations, epidermal nevi, cerebriform connective tissue nevi (CCTN), and hyperostosis. HHML syndrome may overlap with CLOVES syndrome given that overgrowth can be progressive and spinal complications and scoliosis have been reported [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>].</p>
        <p><bold>SOLAMEN syndrome</bold> is characterized by atypical features of Cowden syndrome including segmental overgrowth, lipomatosis, arteriovenous malformation, and epidermal nevi. It is also associated with tumors such as ovarian cystadenoma, multiple breast tumors, and thyroid adenomas. Fibrocystic breast disease, gingival papules, and multinodular goiter have also been reported. SOLAMEN syndrome results from biallelic inactivation of <italic toggle="yes">PTEN</italic> (type 2 mosaicism), restricted to the atypical lesions [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.caux.2007.767">Caux et al 2007</xref>]. (See <related-object link-type="booklink" source-id="gene" document-id="phts" document-type="chapter"><italic toggle="yes">PTEN</italic> Hamartoma Tumor Syndrome</related-object>.)</p>
      </sec>
      <sec id="pik3ca-overgrowth.Management">
        <title>Management</title>
        <sec id="pik3ca-overgrowth.Evaluations_Following">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>A thorough history to identify key features of <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth</p>
            </list-item>
            <list-item>
              <p>A physical examination including a thorough skin, cardiac, abdominal, and musculoskeletal evaluation, as well as a detailed neurologic assessment</p>
            </list-item>
            <list-item>
              <p>Investigations to detect abnormalities before they result in significant morbidity/mortality:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Baseline brain and spinal cord imaging, especially in children with hemimegalencephaly (HMEG) and MCAP syndrome for early detection of cortical dysplasia, ventriculomegaly, and cerebellar tonsillar ectopia.</p>
                </list-item>
                <list-item>
                  <p>A cardiovascular assessment including a baseline echocardiogram and electrocardiogram to evaluate for cardiovascular malformations and rhythm abnormalities</p>
                </list-item>
                <list-item>
                  <p>A baseline renal ultrasound to evaluate for structural renal abnormalities</p>
                </list-item>
                <list-item>
                  <p>Surgical and orthopedic referrals for individuals suspected of having CLOVES syndrome or fibroadipose hyperplasia, and individuals with MCAP syndrome with focal somatic overgrowth or leg-length discrepancy</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="pik3ca-overgrowth.Treatment_of_Manifesta">
          <title>Treatment of Manifestations</title>
          <p>Patients with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth benefit from a coordinated and multidisciplinary clinical approach tailored to the individual&#x02019;s specific needs and manifestations.</p>
          <p>Referral to the appropriate specialist(s) is recommended for the following findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Significant or lipomatous segmental overgrowth: referral to a surgeon and/or thoracic surgeon (when lipomatous overgrowth involves the trunk)</p>
            </list-item>
            <list-item>
              <p>Leg-length discrepancy secondary to segmental somatic overgrowth</p>
            </list-item>
            <list-item>
              <p>Cardiac abnormalities (i.e., structural cardiovascular disease and arrhythmias)</p>
            </list-item>
            <list-item>
              <p>Renal abnormalities</p>
            </list-item>
            <list-item>
              <p>Intellectual disability and/or difficulties with learning, behavior, or speech, or motor difficulties</p>
            </list-item>
            <list-item>
              <p>Speech, swallowing, and feeding difficulties</p>
            </list-item>
          </list>
          <p>
            <bold>Neurologic and neurosurgical manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>MCAP syndrome.</bold> Findings warranting neurosurgical referral include rapidly enlarging OFC, obstructive hydrocephalus, symptoms of raised intracranial pressure, and progressive or symptomatic cerebellar tonsillar ectopia (CBTE) or Chiari malformation. Early treatment of hydrocephalus may reduce the risk for progressive CBTE, but data are lacking to determine the most appropriate neurosurgical management. In recent years, favorable outcomes have been observed with ventriculostomy of the third ventricle (rather than insertion of a ventriculo-peritoneal shunt), suggesting that the neurosurgical management of hydrocephalus in MCAP syndrome is evolving.</p>
            </list-item>
            <list-item>
              <p><bold>HMEG.</bold> Individuals are at risk for severe early-onset epilepsy, focal neurologic signs such as hemiparesis, and severe intellectual disability. Epilepsy and intellectual disability may be improved by hemispherectomy [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.di_rocco.2006.852">Di Rocco et al 2006</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kwan.2008.643">Kwan et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Individuals with HMEG and MCAP syndrome with polymicrogyria (PMG) are at increased risk for epilepsy; thus, long-term neurologic follow up is warranted, and many require long-term antiepileptic treatment [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Somatic overgrowth, vascular, lymphatic and musculoskeletal manifestations.</bold> CLOVES syndrome and fibroadipose hyperplasia (FH) are associated with severe focal overgrowth, vascular malformations, and orthopedic complications with significant morbidities. Prompt diagnosis (by MR/CT and angiography) is warranted. Most individuals undergo (often several) debulking or orthopedic procedures with significant ensuing complications (see <xref ref-type="sec" rid="pik3ca-overgrowth.Surveillance">Surveillance</xref>).</p>
          <p>The following are the main treatment considerations in CLOVES syndrome:</p>
          <list list-type="bullet">
            <list-item>
              <p>The characteristic truncal lipomatous mass infiltrates surrounding tissues and often requires surgical excision. Severe scoliosis, large truncal mass, paraspinal high-flow lesions with spinal cord ischemia, lymphatic malformations, cutaneous vesicles, orthopedic problems of the feet and hands, and central phlebectasia/thromboembolism are examples of significant morbidities that need active or prophylactic medical intervention.</p>
            </list-item>
            <list-item>
              <p>Paraspinal and intraspinal extension have significant risk for compression of the cord, thecal sac, and nerve roots, with resultant major neurologic deficits, warranting prompt diagnosis and multidisciplinary care [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>].</p>
            </list-item>
            <list-item>
              <p>Given the risk for thromboembolism in CLOVES syndrome, appropriate prophylactic measures including anticoagulation and caval filtration, particularly in the perioperative period, are recommended. Central and thoracic phlebectasia in individuals with CLOVES syndrome should be considered an indication for placement of a superior vena cava (SVC) filter.</p>
            </list-item>
          </list>
          <p>FH is associated with severe progressive overgrowth of fibrous and adipose tissues. While the severity and natural history varied among reported individuals, thorough surgical and orthopedic evaluations are warranted. Most individuals (8/10) underwent extensive debulking or orthopedic procedures.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Surveillance">
          <title>Surveillance</title>
          <p><bold>MCAP syndrome.</bold> Provisional surveillance guidelines include regular follow up, no less than every six months until age six years, and at least yearly thereafter. At each visit, the following are recommended with appropriate testing for any positive finding:</p>
          <list list-type="bullet">
            <list-item>
              <p>A medical history with attention to:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Childhood cancer</p>
                </list-item>
                <list-item>
                  <p>Breathing or sleep problems</p>
                </list-item>
                <list-item>
                  <p>Seizures or other undefined spells, headaches, or new or worsening neurologic symptoms</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A detailed neurologic evaluation</p>
            </list-item>
            <list-item>
              <p>Brain MRI. Based on limited retrospective data available, the risk for hydrocephalus, cerebellar tonsillar ectopia, or both with low brain stem or high spinal cord compression, appears to be highest in the first two years. Brain MRI is provisionally recommended every six months from birth to age two years, and annually from age two to six years. In older individuals, the frequency should be based on prior results and clinical findings, with particular attention to apnea or other abnormal patterns of respiration, headaches, changes in gait, or other neurologic problems.</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound. Until additional data are available, screening for Wilms tumor following guidelines developed for <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedemann syndrome</related-object> may be considered (i.e., renal ultrasound examination every 3 months until age 8 years).</p>
            </list-item>
          </list>
          <p>
            <bold>CLOVES syndrome</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Given the associated morbidities including severe scoliosis, infiltrative lipomatous overgrowth, paraspinal high-flow lesions with spinal cord ischemia, lymphatic malformations, cutaneous vesicles, orthopedic problems, central phlebectasias and thromboembolism, individuals with CLOVES syndrome require surveillance tailored to their specific needs with particular attention to surgical care [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.215">Alomari 2011</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.1812">Alomari et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>Commonly occurring postoperative complications of surgical excision of the truncal lipomatous mass include recurrence, hypervascularity, and infiltrative growth. Therefore, diligent surgical care and monitoring are recommended.</p>
            </list-item>
          </list>
          <p><bold>Fibroadipose hyperplasia.</bold> Data regarding the natural history of fibroadipose hyperplasia are limited. However, given the extensive degree of somatic overgrowth in most individuals, the same surveillance guidelines for CLOVES are tentatively recommended for individuals with FH [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>].</p>
        </sec>
        <sec id="pik3ca-overgrowth.Evaluation_of_Relative">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="pik3ca-overgrowth.Related_Genetic_Counse">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Therapies_Under_Invest">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="pik3ca-overgrowth.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth is not known to be inherited. No confirmed vertical transmission or sib recurrence has been reported.</p>
          <p>The molecular data show that 21 of 24 affected individuals had somatic mosaicism for pathogenic variants in <italic toggle="yes">PIK3CA</italic> [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>], suggesting that mutation occurred post-fertilization in one cell of the multicellular embryo. Two individuals with MCAP syndrome had a <italic toggle="yes">de novo</italic> germline pathogenic variant in <italic toggle="yes">PIK3CA</italic> [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. The third had only one tissue tested with inconclusive results.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband.</bold> No parent of a child with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth has had any significant, distinctive manifestations of the disorder nor would such a finding be expected, given the somatic mutational mechanism of these disorders.</p>
          <p><bold>Sibs of a proband.</bold> The risk to sibs of a proband with somatic mosaicism for a pathogenic variant in <italic toggle="yes">PIK3CA</italic> would be expected to be the same as in the general population.</p>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Reproductive outcome data on adults with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth are limited; there are no instances of vertical transmission of these disorders. While adults with MCAP syndrome, CLOVES syndrome, and fibroadipose hyperplasia have been reported, the developmental outcome of individuals with hemimegalencephaly (HMEG) is poor.</p>
            </list-item>
            <list-item>
              <p>All but three affected individuals with MCAP syndrome had somatic mosaicism for a pathogenic variant in <italic toggle="yes">PIK3CA</italic>, suggesting that mutation occurred post-fertilization in one cell of the multicellular embryo. Therefore the risk for transmission to offspring is expected to be less than 50%.</p>
            </list-item>
            <list-item>
              <p>Two individuals with MCAP syndrome had a <italic toggle="yes">de novo</italic> germline pathogenic variant in <italic toggle="yes">PIK3CA</italic> [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]; therefore, offspring of these individuals have a 50% risk of inheriting the <italic toggle="yes">PIK3CA</italic> pathogenic variant.</p>
            </list-item>
          </list>
          <p><bold>Other family members of a proband.</bold> The risk to other family members is the same as that of the general population.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Related_Genetic_Counse">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mosaic pathogenic variant.</bold> This is a relatively new area for clinical genetics as only a small (albeit growing) number of disorders is known to be caused by this genetic mechanism.</p>
          <p>Counseling for recurrence risk in <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth should emphasize that, while no pregnancy is at zero risk, all evidence suggests that the risk for recurrence is not increased, compared to the general population. The rare families with MCAP syndrome caused by a <italic toggle="yes">de novo</italic> germline <italic toggle="yes">PIK3CA</italic> pathogenic variant should be counseled regarding the theoretic risk for parental germline mosaicism, which is estimated at less than 1%.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>Because <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth is not inherited, family members are not known to be at increased risk of being affected and prenatal diagnosis is usually not indicated for family members. However, low-level germline mosaicism may theoretically be present in a parent of a child with a germline <italic toggle="yes">PIK3CA</italic> pathogenic variant. Prenatal diagnosis, either through a clinical laboratory or a laboratory offering custom prenatal testing, may be an option for such rare families.</p>
          <p>In addition, prenatal testing may be an option for pregnancies identified by ultrasound examination to be at risk for these syndromes.</p>
          <list list-type="bullet">
            <list-item>
              <p>Findings on ultrasound examination that suggest MCAP syndrome include marked fetal overgrowth and progressive macrocephaly with no indication of maternal hyperglycemia or fetal hyperinsulinism. Other reported fetal ultrasound findings include ventriculomegaly, pleural effusions, polyhydramnios, hydrops, limb asymmetry, and frontal bossing [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.nyberg.2005.129">Nyberg et al 2005</xref>]. A fetal MRI in an affected fetus with megalencephaly and ventriculomegaly revealed diffuse bilateral polymicrogyria and polysyndactyly of one foot [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.gripp.2009.868">Gripp et al 2009</xref>].</p>
            </list-item>
            <list-item>
              <p>Findings on prenatal ultrasound examination in CLOVES syndrome include prenatal overgrowth, lipomatous truncal masses, and vascular or lymphatic malformations [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.sapp.2007.2944">Sapp et al 2007</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2009a.1">Alomari 2009a</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.alomari.2011.1812">Alomari et al 2011</xref>].</p>
            </list-item>
          </list>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold>. Because the <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth syndromes are not inherited, family members are not known to have an increased risk of being affected. The authors recognize no potential role for PGD in these syndromes.</p>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.Resources">
        <title>Resources</title>
      </sec>
      <sec id="pik3ca-overgrowth.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="pik3ca-overgrowth.Molecular_Genetic_Path">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The PI3Ks are members of a unique and highly conserved family of intracellular lipid kinases that phosphorylate the 3&#x02019;-hydroxyl group of phosphatidylinositol and phosphoinositides, a reaction that leads to the activation of many complex and intricate intracellular signaling pathways including the PI3K-AKT-mTOR network. Class IA PI3Ks are activated by growth factor receptor tyrosine kinases (RTKs) and are composed of heterodimers of p110 catalytic and p85 regulatory subunits, each of which has several isoforms encoded by three genes; <italic toggle="yes">PIK3R1, PIK3R2,</italic> and <italic toggle="yes">PIK3R3</italic> encode the p85&#x003b1;, p55&#x003b1;, p50&#x003b1;, p85&#x003b2;, and p55&#x003b3; isoforms of the p85 regulatory subunit, while <italic toggle="yes">PIK3CA</italic>, <italic toggle="yes">PIK3CB,</italic> and <italic toggle="yes">PIK3CD</italic> encode the highly homologous p110 catalytic subunit isoforms p110&#x003b1;, p110&#x003b2;, and p110&#x003b4;, respectively [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.fruman.1998.481">Fruman et al 1998</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.cantley.2002.1655">Cantley 2002</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.engelman.2006.606">Engelman et al 2006</xref>].</p>
          <p>Somatic pathogenic gain-of-function variants <italic toggle="yes">PIK3CA</italic> are frequently found in individuals without <italic toggle="yes">PIK3CA</italic>-related overgrowth in diverse cancers including colon, breast, brain, liver, stomach, and lung. See <xref ref-type="sec" rid="pik3ca-overgrowth.Cancer_and_Benign_Tumo">Cancer and Benign Tumors</xref>.</p>
          <p><bold>Gene structure.</bold> The <italic toggle="yes">PIK3CA</italic> (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha gene) encodes the p110&#x003b1; catalytic subunit of class IA PI3K. <italic toggle="yes">PIK3CA</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006218.2">NM_006218.2</ext-link>) comprises 21 coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="pik3ca-overgrowth" object-id="pik3ca-overgrowth.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> A number of benign variants have been identified [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.quaye.2009.993">Quaye et al 2009</xref>]. A pseudogene with greater than 95% homology spanning exons 9 to 13 of <italic toggle="yes">PIK3CA</italic> on chromosome 22 exists [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.m_ller.2007.27">M&#x000fc;ller et al 2007</xref>].</p>
          <p><bold>Pathogenic variants.</bold> Eighteen pathogenic variants have been reported in MCAP syndrome, hemimegalencephaly (HMEG), and CLOVES syndrome and fibroadipose hyperplasia [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. See <xref ref-type="table" rid="pik3ca-overgrowth.T.summary_of_molecular">Table 3</xref> and <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>MCAP syndrome.</bold> The <italic toggle="yes">PIK3CA</italic> variant spectrum in MCAP syndrome is wide. <italic toggle="yes">PIK3CA</italic> pathogenic variants were detected in 24 individuals with MCAP syndrome using both standard and massively parallel sequencing methods [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>]. It is currently unknown whether MCAP syndrome is genetically heterogeneous or the individuals with MCAP syndrome of unknown cause are in fact heterozygous for low-level mosaic <italic toggle="yes">PIK3CA</italic> pathogenic variants undetected in the tissue(s) tested.</p>
            </list-item>
            <list-item>
              <p><bold>CLOVES syndrome and fibroadipose hyperplasia.</bold> Mosaic <italic toggle="yes">PIK3CA</italic> pathogenic variants from affected (or lesional) tissues were identified in six individuals with CLOVES syndrome and ten individuals with fibroadipose hyperplasia [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>]. See <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>.</p>
            </list-item>
          </list>
          <table-wrap id="pik3ca-overgrowth.T.select_pik3ca_varian" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Select <italic toggle="yes">PIK3CA</italic> Variants Causing <italic toggle="yes">PIK3CA</italic>-Related Overgrowth Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Overgrowth Phenotype (N)</th>
                  <th id="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference<break/>Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1258T&#x0003e;C</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys420Arg</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CLOVES (2)</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_4" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_006218.2">NM_006218.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_006209.2">NP_006209.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1625G&#x0003e;A</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu542Lys</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CLOVES (2)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1633G&#x0003e;A</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu545Lys</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">HMEG (4)&#x000a0;<sup>1</sup>, MCAP-plus (1)&#x000a0;<sup>2</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3140A&#x0003e;G</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His1047Arg</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CLOVES-FH (9), KTS (3)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3140A&#x0003e;T</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His1047Leu</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">CLOVES-FH (2)</td>
                </tr>
                <tr>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Others</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Others</td>
                  <td headers="hd_h_pik3ca-overgrowth.T.select_pik3ca_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">MCAP (23)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.4.1">
                <label>1. </label>
                <p>p.Glu545Lys was identified in all four <italic toggle="yes">PIK3CA</italic>-positive brain tissue samples from individuals with HMEG [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>].</p>
              </fn>
              <fn id="pik3ca-overgrowth.TF.4.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="pik3ca-overgrowth.Cancer_and_Benign_Tumo">Cancer and Benign Tumors</xref> for a description of this phenotype.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p>Many of the pathogenic missense variants in <italic toggle="yes">PIK3CA</italic> have been found in human cancers. See <xref ref-type="sec" rid="pik3ca-overgrowth.Cancer_and_Benign_Tumo">Cancer and Benign Tumors</xref>.</p>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">PIK3CA</italic> encodes 1068 amino acids of the p110&#x003b1; catalytic subunit of class IA PI3K. Similar to most genes encoding PI3Ks, <italic toggle="yes">PIK3CA</italic> is widely expressed. p110&#x003b1; is characterized by five functional domains: p85-regulatory subunit-binding domain (p85-BD), Ras-binding domain (Ras-BD), C2 domain, helical domain, and kinase catalytic domain [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.chalhoub.2009.127">Chalhoub &#x00026; Baker 2009</xref>].</p>
          <p><bold>Abnormal gene product.</bold> In cell lines from individuals with <italic toggle="yes">PIK3CA</italic>-associated overgrowth, stimulation of cells resulted in increased basal hyperphosphorylation of AKT and its downstream targets (e.g., p70S6 kinases), suggesting that <italic toggle="yes">PIK3CA</italic> pathogenic variants in <italic toggle="yes">PIK3CA</italic>-associated overgrowth result in enhanced basal activity and activation of downstream signaling of the PI3K-AKT pathway [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>].</p>
          <sec id="pik3ca-overgrowth.Cancer_and_Benign_Tumo">
            <title>Cancer and Benign Tumors</title>
            <p>Somatic pathogenic gain-of-function variants in <italic toggle="yes">PIK3CA</italic> are frequently found in diverse cancer types including ovary, breast, lung, brain, stomach, and up to 15%-20% of colorectal cancers. The helical and kinase domains are particular hot spots for somatic pathogenic variants in cancer [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.janku.2011.e22769">Janku et al 2011</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.janku.2012.1566">Janku et al 2012</xref>]. All cancer-associated <italic toggle="yes">PIK3CA</italic> variants for which functional data are available were shown to result in increased PI3K activity and/or signaling [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.shayesteh.1999.99">Shayesteh et al 1999</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.liu.2011.1116">Liu et al 2011</xref>]. Detectable amplification of the gene has also been shown in 58% of ovarian tumors using fluorescence in situ hybridization [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.shayesteh.1999.99">Shayesteh et al 1999</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.zhang.2003.4225">Zhang et al 2003</xref>].</p>
            <p>Among the approximately 160 <italic toggle="yes">PIK3CA</italic> pathogenic variants listed in the Catalogue of Somatic Mutations in Cancer (COSMIC), common variants in four amino acids (p.Glu542Lys, p.Glu545Lys in exon 9, and p.His1047Arg and p.His1047Leu in exon 20) account for 80% of tumor-associated <italic toggle="yes">PIK3CA</italic> variants and show the highest oncogenic activity [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.samuels.2004.554">Samuels et al 2004</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.samuels.2006.77">Samuels &#x00026; Ericson 2006</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.janku.2012.1566">Janku et al 2012</xref>]. See <xref ref-type="table" rid="pik3ca-overgrowth.T.common_cancerrelated">Table 5</xref>.</p>
            <table-wrap id="pik3ca-overgrowth.T.common_cancerrelated" orientation="portrait" position="anchor">
              <label>Table 5. </label>
              <caption>
                <p>Common Cancer-Related <italic toggle="yes">PIK3CA</italic> Variants Reported in COSMIC Database</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                    <th id="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"># of Cancer Specimens with the Pathogenic Variant</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1625G&#x0003e;A</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu542Lys</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">633</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1633G&#x0003e;A</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu545Lys</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">977</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3140A&#x0003e;G</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His1047Arg</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1680</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3140A&#x0003e;T</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His1047Leu</td>
                    <td headers="hd_h_pik3ca-overgrowth.T.common_cancerrelated_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">201</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC: Catalogue of Somatic Mutations in Cancer</ext-link>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>The same four <italic toggle="yes">PIK3CA</italic> missense variants may be found in individuals with <italic toggle="yes">PIK3CA</italic>-associated overgrowth and in unaffected individuals with <italic toggle="yes">PIK3CA</italic>-related cancer (<xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref> and <xref ref-type="table" rid="pik3ca-overgrowth.T.common_cancerrelated">Table 5</xref>). Preliminary analysis (see <xref ref-type="sec" rid="pik3ca-overgrowth.GenotypePhenotype_Corr">Genotype-Phenotype Correlations</xref>) of individuals with <italic toggle="yes">PIK3CA</italic>-associated segmental overgrowth suggests that MCAP syndrome is primarily associated with somatic mosaicism for <italic toggle="yes">PIK3CA</italic> pathogenic variants not commonly identified in tumors, whereas hemimegalencephaly and CLOVES syndrome are associated with somatic mosaicism for <italic toggle="yes">PIK3CA</italic> pathogenic variants at the cancer-related mutational hot spots (see <xref ref-type="sec" rid="pik3ca-overgrowth.Molecular_Genetics">Molecular Genetics</xref>, <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>, and <xref ref-type="table" rid="pik3ca-overgrowth.T.common_cancerrelated">Table 5</xref>).</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>HMEG.</bold> p.Glu545Lys was identified in brain tissues of all four individuals with HMEG [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lee.2012.941">Lee et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>MCAP syndrome.</bold> While 13 of the 15 reported <italic toggle="yes">PIK3CA</italic> pathogenic variants in MCAP syndrome are reported in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</ext-link>, only one (p.Glu545Lys) was at a site commonly mutated in <italic toggle="yes">PIK3CA</italic>-related cancers. This was identified in a child with atypical MCAP syndrome features that overlapped with CLOVES syndrome and hemimegalencephaly, including severe asymmetric brain overgrowth, bilateral cortical dysplasia, severe focal overgrowth of the digits, and epidermal nevi (designated as MCAP-plus in <xref ref-type="table" rid="pik3ca-overgrowth.T.select_pik3ca_varian">Table 4</xref>) [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.rivi_re.2012.934">Rivi&#x000e8;re et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>CLOVES syndrome and fibroadipose hyperplasia.</bold> 14 individuals with these phenotypes have <italic toggle="yes">PIK3CA</italic> pathogenic variants involving three of the four cancer mutational hot spots [<xref ref-type="bibr" rid="pik3ca-overgrowth.REF.kurek.2012.1108">Kurek et al 2012</xref>, <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.lindhurst.2012.928">Lindhurst et al 2012</xref>].</p>
              </list-item>
            </list>
          </sec>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.References">
        <title>References</title>
        <sec id="pik3ca-overgrowth.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="pik3ca-overgrowth.Literature_Cited.reflist0">
            <ref id="pik3ca-overgrowth.REF.abdelhalim.2003.534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Abdelhalim</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moritani</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richfield</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekholm</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westesson</surname>
                    <given-names>PL</given-names>
                  </name>
                </person-group>
                <article-title>Epidermal nevus syndrome: megalencephaly with bihemispheric and cerebellar involvement: imaging and neuropathologic correlation.</article-title>
                <source>J Comput Assist Tomogr.</source>
                <year>2003</year>
                <volume>27</volume>
                <fpage>534</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12886138</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.akcar.2004.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Akcar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adapinar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dinleyici</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durak</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozkan</surname>
                    <given-names>IR</given-names>
                  </name>
                </person-group>
                <article-title>A case of macrocephaly-cutis marmorata telangiectatica congenita and review of neuroradiologic features.</article-title>
                <source>Ann Genet.</source>
                <year>2004</year>
                <volume>47</volume>
                <fpage>261</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15337471</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.alomari.2010.459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedequist</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism.</article-title>
                <source>J Thorac Cardiovasc Surg.</source>
                <year>2010</year>
                <volume>140</volume>
                <fpage>459</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">20537357</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.alomari.2011.1812">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaudry</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodesch</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burrows</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orbach</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <article-title>Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>1812</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21310861</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.alomari.2009a.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                </person-group>
                <article-title>Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>2009a</year>
                <volume>18</volume>
                <fpage>1</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19011570</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.alomari.2009b.294">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                </person-group>
                <article-title>CLOVE(S) syndrome: expanding the acronym.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009b</year>
                <volume>149A</volume>
                <fpage>294</fpage>
                <pub-id pub-id-type="pmid">19161149</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.alomari.2011.215">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                </person-group>
                <article-title>Comments on the diagnosis and management of CLOVES syndrome.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2011</year>
                <volume>28</volume>
                <fpage>215</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21504461</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.barkovich.1990.523">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chuang</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <article-title>Unilateral megalencephaly: correlation of MR imaging and pathologic characteristics.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>1990</year>
                <volume>11</volume>
                <fpage>523</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">1693466</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.barkovich.2005.1873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzniecky</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>A developmental and genetic classification for malformations of cortical development.</article-title>
                <source>Neurology.</source>
                <year>2005</year>
                <volume>65</volume>
                <fpage>1873</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">16192428</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.biesecker.1999.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Happle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Viljoen</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>MM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation.</article-title>
                <source>Am J Med Genet.</source>
                <year>1999</year>
                <volume>84</volume>
                <fpage>389</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">10360391</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.cantley.2002.1655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cantley</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>The phosphoinositide 3-kinase pathway.</article-title>
                <source>Science.</source>
                <year>2002</year>
                <volume>296</volume>
                <fpage>1655</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12040186</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.caux.2007.767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Caux</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plauchu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chibon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fain</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vabres</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selma</surname>
                    <given-names>ZB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laroche</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e9;rard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longy</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2007</year>
                <volume>15</volume>
                <fpage>767</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">17392703</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.chalhoub.2009.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chalhoub</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>SJ</given-names>
                  </name>
                </person-group>
                <article-title>PTEN and the PI3-kinase pathway in cancer.</article-title>
                <source>Annu Rev Pathol.</source>
                <year>2009</year>
                <volume>4</volume>
                <fpage>127</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">18767981</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.claytonsmith.1997.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerr</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mueller</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brueton</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Super</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steen-Johnsen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donnai</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly with cutis marmorata, haemangioma and syndactyly--a distinctive overgrowth syndrome.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>1997</year>
                <volume>6</volume>
                <fpage>291</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">9354837</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.cohen.2003.49">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>MM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <year>2003</year>
                <volume>117C</volume>
                <fpage>49</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">12561058</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.colombani.2006.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colombani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chouchane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pitelet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morales</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinard</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lion-Fran&#x000e7;ois</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mugneret</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guibaud</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>A new case of megalencephaly and perisylvian polymicrogyria with post-axial polydactyly and hydrocephalus: MPPH syndrome.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2006</year>
                <volume>49</volume>
                <fpage>466</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16807158</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.conway.2007a.296">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danielpour</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Surgical management of cerebellar tonsillar herniation in three patients with macrocephaly-cutis marmorata telangiectatica congenita. Report of three cases.</article-title>
                <source>J Neurosurg.</source>
                <year>2007a</year>
                <volume>106</volume>
                <fpage>296</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">17465364</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.conway.2007b.2981">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pressman</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danielpour</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Lara</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitta</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyme</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shieh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moeschler</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crandall</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauzon</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viskochil</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Neuroimaging findings in macrocephaly-capillary malformation: a longitudinal study of 17 patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007b</year>
                <volume>143A</volume>
                <fpage>2981</fpage>
                <lpage>3008</lpage>
                <pub-id pub-id-type="pmid">18000912</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.coste.2012.917">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coste</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarret</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cisse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delabaere</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francannet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanlieferinghen</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-capillary malformation. A neonatal case</article-title>
                <source>Arch Pediatr.</source>
                <year>2012</year>
                <volume>19</volume>
                <fpage>917</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">22884750</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.debaun.1998.398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DeBaun</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry.</article-title>
                <source>J Pediatr.</source>
                <year>1998</year>
                <volume>132</volume>
                <fpage>398</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">9544889</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.di_rocco.2006.852">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battaglia</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piastra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massimi</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Hemimegalencephaly: clinical implications and surgical treatment.</article-title>
                <source>Childs Nerv Syst.</source>
                <year>2006</year>
                <volume>22</volume>
                <fpage>852</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16821075</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.dinleyici.2004.366">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dinleyici</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tekin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksit</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adapinar</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozan</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-Cutis marmorata telangiectatica congenita with atrial septal aneurysm and magnetic resonance imaging (MRI) findings.</article-title>
                <source>Pediatr Int.</source>
                <year>2004</year>
                <volume>46</volume>
                <fpage>366</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15151560</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.engelman.2006.606">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engelman</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantley</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.</article-title>
                <source>Nat Rev Genet.</source>
                <year>2006</year>
                <volume>7</volume>
                <fpage>606</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">16847462</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.ercan.2013.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ercan</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oztunc</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Celkan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kizilkilic</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vural</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perk</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Islak</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuysuz</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-capillary malformation syndrome in a newborn with tetralogy of fallot and sagittal sinus thrombosis.</article-title>
                <source>J Child Neurol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>115</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22451530</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.floressarnat.2003.776">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flores-Sarnat</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarnat</surname>
                    <given-names>HB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e1;vila-Guti&#x000e9;rrez</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Hemimegalencephaly: part 2. Neuropathology suggests a disorder of cellular lineage.</article-title>
                <source>J Child Neurol.</source>
                <year>2003</year>
                <volume>18</volume>
                <fpage>776</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">14696906</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.floressarnat.2002.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flores-Sarnat</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects.</article-title>
                <source>J Child Neurol.</source>
                <year>2002</year>
                <volume>17</volume>
                <fpage>373</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">12150586</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.franceschini.2000.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Franceschini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licata</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Cara</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschini</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genitori</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-Cutis marmorata telangiectatica congenita without cutis marmorata?</article-title>
                <source>Am J Med Genet.</source>
                <year>2000</year>
                <volume>90</volume>
                <fpage>265</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10710221</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.fruman.1998.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fruman</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyers</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantley</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Phosphoinositide kinases.</article-title>
                <source>Annu Rev Biochem.</source>
                <year>1998</year>
                <volume>67</volume>
                <fpage>481</fpage>
                <lpage>507</lpage>
                <pub-id pub-id-type="pmid">9759495</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.garavelli.2007.200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Garavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guareschi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errico</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergonzini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zollino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frigieri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zonari</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giustina</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amarri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banchini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus (MPPH): report of a new case.</article-title>
                <source>Neuropediatrics.</source>
                <year>2007</year>
                <volume>38</volume>
                <fpage>200</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18058629</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.giuliano.2004.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giuliano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edery</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigaudy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philip</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-cutis marmorata telangiectatica congenita: seven cases including two with unusual cerebral manifestations.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>126A</volume>
                <fpage>99</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">15039980</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.gripp.2009.868">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinkler</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malinger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Significant overlap and possible identity of macrocephaly capillary malformation and megalencephaly polymicrogyria-polydactyly hydrocephalus syndromes.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009</year>
                <volume>149A</volume>
                <fpage>868</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">19353582</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.gucev.2008.2688">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gucev</surname>
                    <given-names>ZS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tasic</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jancevska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konstantinova</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pop-Jordanova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trajkovski</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2008</year>
                <volume>146A</volume>
                <fpage>2688</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">18816642</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.janku.2011.e22769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janku</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsimberidou</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naing</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchook</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luthra</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrido-Laguna</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurzrock</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.</article-title>
                <source>PLoS One.</source>
                <year>2011</year>
                <volume>6</volume>
                <fpage>e22769</fpage>
                <pub-id pub-id-type="pmid">21829508</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.janku.2012.1566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Janku</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheler</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naing</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stepanek</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchook</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrido-Laguna</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsimberidou</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piha-Paul</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulder</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luthra</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurzrock</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>PIK3CA mutations in advanced cancers: characteristics and outcomes.</article-title>
                <source>Oncotarget.</source>
                <year>2012</year>
                <volume>3</volume>
                <fpage>1566</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">23248156</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.kariminejad.2013.651">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kariminejad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Radmanesh</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rezayi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonekaboni</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome: a case report.</article-title>
                <source>J Child Neurol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>651</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22859694</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.klein.2012.1690">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghahremani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Agosto</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Phenotypic progression of skeletal anomalies in CLOVES syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>1690</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22628280</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.kuint.2012.384">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kuint</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Globus</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Simon</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberger</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-capillary malformation presenting with fetal arrhythmia.</article-title>
                <source>Pediatr Dermatol.</source>
                <year>2012</year>
                <volume>29</volume>
                <fpage>384</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22329570</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.kurek.2012.1108">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurek</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luks</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayturk</surname>
                    <given-names>UM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alomari</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spencer</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowen</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozakewich</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <article-title>Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>1108</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">22658544</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.kwan.2008.643">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kwan</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shyu</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>TT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chang</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yiu</surname>
                    <given-names>CH</given-names>
                  </name>
                </person-group>
                <article-title>Corpus callosotomy in a patient of hemimegalencephaly and Lennox-Gastaut syndrome.</article-title>
                <source>Brain Dev.</source>
                <year>2008</year>
                <volume>30</volume>
                <fpage>643</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18439776</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.lapunzina.2004.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lapunzina</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gair&#x000ed;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delicado</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torres</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pajares</surname>
                    <given-names>IL</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>130A</volume>
                <fpage>45</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15368495</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.lee.2012.941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huynh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silhavy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon-Salazar</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heiberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bafna</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collazo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funari</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russ</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabriel</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathern</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <article-title>De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>941</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22729223</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.lindhurst.2012.928">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindhurst</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parker</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudge</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Witkowski</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groeneveld</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huson</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tosi</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gucev</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tziotzios</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helliwell</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Rahilly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savage</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakelam</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barroso</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semple</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>928</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">22729222</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.lindhurst.2011.611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lindhurst</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teer</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnston</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Finn</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cannons</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakemore</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blumhorst</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calder</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deardorff</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Everman</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenstein</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keppler-Noreuil</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuznetsov</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothenberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singhal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tirabosco</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wientroub</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackai</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoag</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitewood-Neal</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robey</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzberg</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darling</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tosi</surname>
                    <given-names>LL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullikin</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>A mosaic activating mutation in AKT1 associated with the Proteus syndrome.</article-title>
                <source>N Engl J Med.</source>
                <year>2011</year>
                <volume>365</volume>
                <fpage>611</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">21793738</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.liu.2011.1116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santiago</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raeder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isabella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semaan</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monahan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlegel</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beroukhim</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <article-title>Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms.</article-title>
                <source>Nat Med.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>1116</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">21822287</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.mart_nezglez.2010.3101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Glez</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romanelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gracia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segovia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Meneses</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez-Gutierrez</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gean</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lapunzina</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-capillary malformation: Analysis of 13 patients and review of the diagnostic criteria.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>3101</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21077203</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.mart_nezlage.2010.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Lage</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guill&#x000e9;n-Navarro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almagro</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Felipe-Murcia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez L&#x000f3;pez-Guerrero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galarza</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Hydrocephalus and Chiari type 1 malformation in macrocephaly-cutis marmorata telangiectatica congenita: a case-based update.</article-title>
                <source>Childs Nerv Syst.</source>
                <year>2010</year>
                <volume>26</volume>
                <fpage>13</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19763591</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.mcbride.2010.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McBride</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varga</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastore</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manickam</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkin</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herman</surname>
                    <given-names>GE</given-names>
                  </name>
                </person-group>
                <article-title>Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly.</article-title>
                <source>Autism Res.</source>
                <year>2010</year>
                <volume>3</volume>
                <fpage>137</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">20533527</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.m_garban_.2003.184">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Child with overgrowth, pigmentary streaks, polydactyly, and intestinal lymphangiectasia: macrocephaly-cutis marmorata telangiectatica congenita syndrome or new disorder?</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>116A</volume>
                <fpage>184</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12494441</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.mirzaa.2004.353">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dodge</surname>
                    <given-names>NN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glass</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures.</article-title>
                <source>Neuropediatrics.</source>
                <year>2004</year>
                <volume>35</volume>
                <fpage>353</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15627943</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.mirzaa.2012.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>deVries</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkins</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>JM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>269</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">22228622</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.moore.1997.67">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toriello</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abuelo</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bull</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higgins</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Twersky</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities.</article-title>
                <source>Am J Med Genet.</source>
                <year>1997</year>
                <volume>70</volume>
                <fpage>67</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">9129744</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.m_ller.2007.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawamata</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luong</surname>
                    <given-names>QT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koeffler</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <article-title>Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.</article-title>
                <source>Leuk Res.</source>
                <year>2007</year>
                <volume>31</volume>
                <fpage>27</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16764926</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.nyberg.2005.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nyberg</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uotila</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkinen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosendahl</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly-cutis marmorata telangiectatica congenita syndrome--prenatal signs in ultrasonography.</article-title>
                <source>Prenat Diagn.</source>
                <year>2005</year>
                <volume>25</volume>
                <fpage>129</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15712320</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.oduber.2011.262">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oduber</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Horst</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillevis Smitt</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeulders</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendiratta</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harper</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Steensel</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                </person-group>
                <article-title>A proposal for classification of entities combining vascular malformations and deregulated growth.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2011</year>
                <volume>54</volume>
                <fpage>262</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">21356335</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.orloff.2013.76">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orloff</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mester</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eng</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2013</year>
                <volume>92</volume>
                <fpage>76</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">23246288</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.osterling.2011.370">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Osterling</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hedlund</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bale</surname>
                    <given-names>JF</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>MPPH syndrome: two new cases.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2011</year>
                <volume>44</volume>
                <fpage>370</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21481746</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.pavlidis.2012.332">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pavlidis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantalupo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boria</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pisani</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Hemimegalencephalic variant of epidermal nevus syndrome: case report and literature review.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2012</year>
                <volume>16</volume>
                <fpage>332</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">22200538</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.pisano.2008.916">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pisano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cianchetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nucaro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pruna</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly, polymicrogyria, and hydrocephalus (MPPH) syndrome: a new case with syndactyly.</article-title>
                <source>J Child Neurol.</source>
                <year>2008</year>
                <volume>23</volume>
                <fpage>916</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18474936</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.poduri.2012.41">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Poduri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evrony</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elhosary</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beroukhim</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehtinen</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hills</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinzen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barry</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourgeois</surname>
                    <given-names>BF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riviello</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkovich</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ligon</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Somatic activation of AKT3 causes hemispheric developmental brain malformations.</article-title>
                <source>Neuron.</source>
                <year>2012</year>
                <volume>74</volume>
                <fpage>41</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22500628</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.quaye.2009.993">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Quaye</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramus</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gentry-Maharaj</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f8;gdall</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiCioccio</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGuire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Berg</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pike</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wozniak</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossing</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ness</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moysich</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f8;gdall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blaakaer</surname>
                    <given-names>J</given-names>
                  </name>
                  <collab>Ovarian Cancer Association Consortium</collab>
                </person-group>
                <article-title>Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Kr&#x000fc;ger-Kjaer S, Pearce CL, Pharoah PD, Gayther SA. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.</article-title>
                <source>Br J Cancer.</source>
                <year>2009</year>
                <volume>100</volume>
                <fpage>993</fpage>
                <lpage>1001</lpage>
                <pub-id pub-id-type="pmid">19240718</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.rios.2013.444">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rios</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paria</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burns</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Israel</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornelia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wise</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ezaki</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2013</year>
                <volume>22</volume>
                <fpage>444</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">23100325</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.rivi_re.2012.934">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rivi&#x000e8;re</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirzaa</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Roak</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beddaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alcantara</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St-Onge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartzentruber</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gripp</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikkel</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Worthylake</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kramer</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albrecht</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armour</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caluseriu</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cytrynbaum</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drolet</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Innes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lauzon</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reggin</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saggar</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerman-Sagie</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyanik</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zirn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaulieu</surname>
                    <given-names>CL</given-names>
                  </name>
                  <collab>Finding of Rare Disease Genes (FORGE) Canada Consortium</collab>
                </person-group>
                <article-title>Majewski J, Bulman DE, O'Driscoll M, Shendure J, Graham JM Jr, Boycott KM, Dobyns WB. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.</article-title>
                <source>Nat Genet.</source>
                <year>2012</year>
                <volume>44</volume>
                <fpage>934</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">22729224</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.robertson.2000.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gattas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ad&#x000e8;s</surname>
                    <given-names>LC</given-names>
                  </name>
                </person-group>
                <article-title>Macrocephaly--cutis marmorata telangiectatica congenita: report of five patients and a review of the literature.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>1</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10649789</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.samuels.2006.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ericson</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Oncogenic PI3K and its role in cancer.</article-title>
                <source>Curr Opin Oncol.</source>
                <year>2006</year>
                <volume>18</volume>
                <fpage>77</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16357568</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.samuels.2004.554">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Samuels</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silliman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ptak</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gazdar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riggins</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willson</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markowitz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinzler</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogelstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Velculescu</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <article-title>High frequency of mutations of the PIK3CA gene in human cancers.</article-title>
                <source>Science.</source>
                <year>2004</year>
                <volume>304</volume>
                <fpage>554</fpage>
                <pub-id pub-id-type="pmid">15016963</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.sapp.2007.2944">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sapp</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van de Kamp</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lowry</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biesecker</surname>
                    <given-names>LG</given-names>
                  </name>
                </person-group>
                <article-title>Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>2944</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">17963221</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.sharma.2009.12">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sharma</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankhyan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>A.</given-names>
                  </name>
                </person-group>
                <article-title>Hypomelanosis of Ito with hemimegalencephaly.</article-title>
                <source>Dermatol Online J.</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>12</fpage>
                <pub-id pub-id-type="pmid">19951648</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.shayesteh.1999.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shayesteh</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldocchi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godfrey</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinkel</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Powell</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gray</surname>
                    <given-names>JW</given-names>
                  </name>
                </person-group>
                <article-title>PIK3CA is implicated as an oncogene in ovarian cancer.</article-title>
                <source>Nat Genet.</source>
                <year>1999</year>
                <volume>21</volume>
                <fpage>99</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">9916799</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.thong.1999.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thong</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keenan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbord</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A child with hemimegalencephaly, hemihypertrophy, macrocephaly, cutaneous vascular malformation, psychomotor retardation and intestinal lymphangiectasia--a diagnostic dilemma.</article-title>
                <source>Clin Dysmorphol.</source>
                <year>1999</year>
                <volume>8</volume>
                <fpage>283</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10532178</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.tohyama.2007.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tohyama</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akasaka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Megalencephaly and polymicrogyria with polydactyly syndrome.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2007</year>
                <volume>37</volume>
                <fpage>148</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">17675034</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.tore.2009.1620">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tore</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKinney</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagar</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Truwit</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raybaud</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Syndrome of megalencephaly, polydactyly, and polymicrogyria lacking frank hydrocephalus, with associated MR imaging findings.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <year>2009</year>
                <volume>30</volume>
                <fpage>1620</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19369601</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.toriello.2007.3009">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toriello</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <article-title>Accurately renaming macrocephaly-cutis marmorata telangiectatica congenita (M-CMTC) as macrocephaly-capillary malformation (M-CM).</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>3009</fpage>
                <pub-id pub-id-type="pmid">17963258</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.verkerk.2010.1488">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verkerk</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Waterschoot</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douben</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poddighe</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terhal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hahnemann</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Wit</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wafelman</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van der Spek</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Klein</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <article-title>Unbalanced der(5)t(5;20) translocation associated with megalencephaly, perisylvian polymicrogyria, polydactyly and hydrocephalus.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>1488</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">20503325</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.vogels.1998.245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vogels</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Decock</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marien</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickx</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>The macrocephaly-cutis marmorata telangiectatica congenita syndrome. Long-term follow-up data in 4 children and adolescents.</article-title>
                <source>Genet Couns.</source>
                <year>1998</year>
                <volume>9</volume>
                <fpage>245</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">9894160</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.wright.2009.287">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frieden</surname>
                    <given-names>IJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlow</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chamlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaffer</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paller</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <article-title>The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations.</article-title>
                <source>Arch Dermatol.</source>
                <year>2009</year>
                <volume>145</volume>
                <fpage>287</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">19289759</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.yano.2001.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Association of arrhythmia and sudden death in macrocephaly-cutis marmorata telangiectatica congenita syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <year>2001</year>
                <volume>102</volume>
                <fpage>149</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11477607</pub-id>
              </element-citation>
            </ref>
            <ref id="pik3ca-overgrowth.REF.zhang.2003.4225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsaros</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fracchioli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzani</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigault de la Longrais</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubin</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coukos</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma.</article-title>
                <source>Cancer Res.</source>
                <year>2003</year>
                <volume>63</volume>
                <fpage>4225</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">12874030</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="pik3ca-overgrowth.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="pik3ca-overgrowth.Author_Notes">
          <title>Author Notes</title>
          <p>Drs Ghayda Mirzaa and William B Dobyns study the developmental basis of a broad range of developmental brain disorders, with a particular focus on megalencephaly syndromes. They are studying the natural history of <italic toggle="yes">PI3KCA</italic>-associated megalencephaly syndromes and related phenotypes.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We would like to thank the patients, their families, and our collaborators for their valuable contribution to our knowledge about these disorders.</p>
        </sec>
        <sec id="pik3ca-overgrowth.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>15 August 2013 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>11 March 2013 (gm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="pik3ca-overgrowth.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Features of MCAP syndrome. Photographs of an individual with MCAP syndrome demonstrating the apparent macrocephaly with prominent forehead (D); extensive capillary malformations (A-F1); bilateral 2-3-4 toe syndactyly (G,H); 3-4 finger syndactyly (F1,F2); and postaxial polydactyly of the right hand (F1).From <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al [2012]</xref>. Used by permission.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pik3ca-overgrowth-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="pik3ca-overgrowth.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Features of MCAP syndrome. A boy age 40 months with MCAP syndrome (left) and his unaffected twin sister (right). Note left-sided hemihypertrophy, typical facial features, bilateral 2-3 toe syndactyly, and connective tissue dysplasia with loose redundant skin.From Conway et al [2007]. Used by permission.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pik3ca-overgrowth-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="pik3ca-overgrowth.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Characteristic brain MRI of MCAP syndrome in three individuals (A-D, E-H, and I-L). Note: Megalencephaly with a prominent forehead (A, E, I); cerebellar tonsillar ectopia with a large cerebellum and crowded posterior fossa (A, E, I); ventriculomegaly (G) and hydrocephalus (J, K, L); and bilateral perisylvian polymicrogyria (B, D, F, G, H, K, and L).From <xref ref-type="bibr" rid="pik3ca-overgrowth.REF.mirzaa.2012.269">Mirzaa et al [2012]</xref>. Used by permission.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pik3ca-overgrowth-Image003" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="pik3ca-overgrowth.F4" orientation="portrait">
          <label>Figure 4. </label>
          <caption>
            <p>Features of CLOVES syndrome in a child with (A) a large lipomatous truncal mass that extends into the surrounding tissues and an overlying capillary malformation and (B) macrodactyly of the left foot</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pik3ca-overgrowth-Image004" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
